Eric L. Moore

1.7k total citations
20 papers, 1.0k citations indexed

About

Eric L. Moore is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Eric L. Moore has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 14 papers in Psychiatry and Mental health and 5 papers in Molecular Biology. Recurrent topics in Eric L. Moore's work include Migraine and Headache Studies (14 papers), Neuropeptides and Animal Physiology (13 papers) and Trigeminal Neuralgia and Treatments (3 papers). Eric L. Moore is often cited by papers focused on Migraine and Headache Studies (14 papers), Neuropeptides and Animal Physiology (13 papers) and Trigeminal Neuralgia and Treatments (3 papers). Eric L. Moore collaborates with scholars based in United States, Poland and New Zealand. Eric L. Moore's co-authors include Christopher Salvatore, Stefanie A. Kane, Mark O. Urban, Eric D. Crown, Samer R. Eid, Kar-Chan Choong, Darrell A. Henze, Steven I. Baskin, Christopher S. Burgey and Scott D. Mosser and has published in prestigious journals such as Neurology, Biochemical and Biophysical Research Communications and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Eric L. Moore

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric L. Moore United States 13 355 355 272 268 265 20 1.0k
Gaetano De Siena Italy 17 293 0.8× 479 1.3× 459 1.7× 213 0.8× 386 1.5× 45 1.4k
Sonya G. Lehto United States 20 455 1.3× 623 1.8× 470 1.7× 242 0.9× 494 1.9× 28 1.5k
Ilaria M. Marone Italy 14 211 0.6× 383 1.1× 415 1.5× 139 0.5× 250 0.9× 14 942
Marco Sisignano Germany 23 244 0.7× 263 0.7× 702 2.6× 53 0.2× 479 1.8× 46 1.5k
Stephen J. Medhurst United Kingdom 13 253 0.7× 275 0.8× 605 2.2× 74 0.3× 236 0.9× 13 1.0k
Bilal Çiğ Türkiye 23 110 0.3× 355 1.0× 277 1.0× 51 0.2× 350 1.3× 31 1.3k
Diego Varela Chile 21 385 1.1× 326 0.9× 213 0.8× 68 0.3× 825 3.1× 47 1.5k
Mario Barbieri Italy 17 508 1.4× 293 0.8× 272 1.0× 62 0.2× 579 2.2× 47 1.4k
Elena Fonfría United Kingdom 20 264 0.7× 596 1.7× 119 0.4× 52 0.2× 420 1.6× 24 1.4k
Alan Gibson United Kingdom 18 340 1.0× 166 0.5× 632 2.3× 118 0.4× 483 1.8× 34 1.2k

Countries citing papers authored by Eric L. Moore

Since Specialization
Citations

This map shows the geographic impact of Eric L. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric L. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric L. Moore more than expected).

Fields of papers citing papers by Eric L. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric L. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric L. Moore. The network helps show where Eric L. Moore may publish in the future.

Co-authorship network of co-authors of Eric L. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Eric L. Moore. A scholar is included among the top collaborators of Eric L. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric L. Moore. Eric L. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moore, Eric L., Ian M. Bell, Mark E. Fraley, et al.. (2024). Pharmacologic characterization of atogepant: A potent and selective calcitonin gene–related peptide receptor antagonist. Cephalalgia. 44(1). 2215271242–2215271242. 8 indexed citations
2.
Moore, Eric L., Mark E. Fraley, Ian M. Bell, et al.. (2020). Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor. Journal of Pharmacology and Experimental Therapeutics. 373(1). 160–166. 51 indexed citations
3.
Moore, Eric L., Christopher S. Burgey, Mark E. Fraley, et al.. (2019). Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene-Related Peptide Receptor (P4.10-021). Neurology. 92(15_supplement). 2 indexed citations
4.
Wood, Michael R., Shawn J. Stachel, Craig A. Stump, et al.. (2013). (E)-Alkenes as replacements of amide bonds: Development of novel and potent acyclic CGRP receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 24(1). 258–261. 5 indexed citations
5.
Moore, Eric L. & Christopher Salvatore. (2012). Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine. British Journal of Pharmacology. 166(1). 66–78. 75 indexed citations
6.
Bell, Ian M., Craig A. Stump, Steven N. Gallicchio, et al.. (2012). MK-8825: A potent and selective CGRP receptor antagonist with good oral activity in rats. Bioorganic & Medicinal Chemistry Letters. 22(12). 3941–3945. 19 indexed citations
7.
Lim, Kaiser G., Matthew A. Rank, Hirohito Kita, Ashok Patel, & Eric L. Moore. (2011). Neuropeptide levels in nasal secretions from patients with and without chronic cough. Annals of Allergy Asthma & Immunology. 107(4). 360–363. 26 indexed citations
8.
Moore, Eric L., Joseph J. Gingell, Stefanie A. Kane, Debbie L. Hay, & Christopher Salvatore. (2010). Mapping the CGRP receptor ligand binding domain: Tryptophan-84 of RAMP1 is critical for agonist and antagonist binding. Biochemical and Biophysical Research Communications. 394(1). 141–145. 32 indexed citations
9.
Wood, Michael R., Rodney A. Bednar, John F. Fay, et al.. (2010). Novel CGRP receptor antagonists from central amide replacements causing a reversal of preferred chirality. Bioorganic & Medicinal Chemistry Letters. 20(22). 6827–6830. 9 indexed citations
10.
Bell, Ian M., Steven N. Gallicchio, Michael R. Wood, et al.. (2010). Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist. ACS Medicinal Chemistry Letters. 1(1). 24–29. 46 indexed citations
11.
Bell, Ian M., Rodney A. Bednar, John F. Fay, et al.. (2009). The identification of potent, orally bioavailable tricyclic CGRP receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(16). 4740–4742. 5 indexed citations
12.
Wood, Michael R., Craig A. Stump, Ian M. Bell, et al.. (2009). Novel CGRP receptor antagonists through a design strategy of target simplification with addition of molecular flexibility. Bioorganic & Medicinal Chemistry Letters. 19(19). 5787–5790. 10 indexed citations
13.
Stump, Craig A., Ian M. Bell, Rodney A. Bednar, et al.. (2008). The discovery of highly potent CGRP receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(1). 214–217. 23 indexed citations
14.
Moore, Eric L., Christopher S. Burgey, Daniel V. Paone, et al.. (2008). Examining the binding properties of MK-0974: A CGRP receptor antagonist for the acute treatment of migraine. European Journal of Pharmacology. 602(2-3). 250–254. 21 indexed citations
15.
Eid, Samer R., Eric D. Crown, Eric L. Moore, et al.. (2008). HC-030031, a TRPA1 Selective Antagonist, Attenuates Inflammatory- and Neuropathy-Induced Mechanical Hypersensitivity. Molecular Pain. 4. 48–48. 378 indexed citations
16.
17.
Mimeault, Murielle, Sonny L. Johansson, Eric L. Moore, et al.. (2007). Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells. Molecular Cancer Therapeutics. 6(3). 967–978. 78 indexed citations
18.
Baskin, Steven I., et al.. (2006). The pharmacological properties of anisodamine. Journal of Applied Toxicology. 27(2). 116–121. 87 indexed citations
19.
Moore, Eric L., et al.. (1997). Effects of chronic ethanol ingestion on mid-latency auditory evoked potentials depend on length of exposure. Alcohol. 14(3). 269–279. 6 indexed citations
20.
Ford, Byron D., et al.. (1997). Chronic ethanol ingestion produces cholinergic hypofunction in rat brain. Alcohol. 14(1). 93–98. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gaetano De Siena Breakdown of academic impact, for papers by Sonya G. Lehto Breakdown of academic impact, for papers by Ilaria M. Marone Breakdown of academic impact, for papers by Marco Sisignano Breakdown of academic impact, for papers by Stephen J. Medhurst Breakdown of academic impact, for papers by Bilal Çiğ Breakdown of academic impact, for papers by Diego Varela Breakdown of academic impact, for papers by Mario Barbieri Breakdown of academic impact, for papers by Elena Fonfría Breakdown of academic impact, for papers by Alan Gibson
Rankless by CCL
2026